On January 25, 2016, the board of directors of AXIM Biotechnologies, Inc. appointed Seth Yakatan to the company's Advisory Board. Seth Yakatan brings more than 24 years of experience as a corporate finance professional, actively supporting small cap and major companies in achieving corporate, financing and asset monetization objectives through the successful structuring and management of strategic transactions and investments totaling more than several billion dollars in value.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0088 USD | -17.37% | -26.67% | -53.68% |
16/04 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/03 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-53.68% | 2.56M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+40.01% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. Appoints Seth Yakatan to the Advisory Board